FI902244A0 - Salter av azelastin, vilka har foerbaettrad loeslighet. - Google Patents

Salter av azelastin, vilka har foerbaettrad loeslighet.

Info

Publication number
FI902244A0
FI902244A0 FI902244A FI902244A FI902244A0 FI 902244 A0 FI902244 A0 FI 902244A0 FI 902244 A FI902244 A FI 902244A FI 902244 A FI902244 A FI 902244A FI 902244 A0 FI902244 A0 FI 902244A0
Authority
FI
Finland
Prior art keywords
loeslighet
foerbaettrad
azelastin
salter
azelastine
Prior art date
Application number
FI902244A
Other languages
English (en)
Finnish (fi)
Inventor
Helmut Hettche
Reinhard Muckenschnabel
Gerhard Scheffler
Ilona Fleischhauer
Wolfgang Morick
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of FI902244A0 publication Critical patent/FI902244A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FI902244A 1989-05-05 1990-05-04 Salter av azelastin, vilka har foerbaettrad loeslighet. FI902244A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3914859 1989-05-05

Publications (1)

Publication Number Publication Date
FI902244A0 true FI902244A0 (fi) 1990-05-04

Family

ID=6380164

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902244A FI902244A0 (fi) 1989-05-05 1990-05-04 Salter av azelastin, vilka har foerbaettrad loeslighet.

Country Status (17)

Country Link
US (4) US5086050A (es)
EP (1) EP0396069B1 (es)
JP (1) JPH02295987A (es)
AT (1) ATE107643T1 (es)
AU (1) AU622022B2 (es)
CA (1) CA2016089C (es)
DD (1) DD294254A5 (es)
DE (2) DE4013696A1 (es)
DK (1) DK0396069T3 (es)
ES (1) ES2055216T3 (es)
FI (1) FI902244A0 (es)
HU (1) HU206110B (es)
IE (1) IE63662B1 (es)
NO (1) NO901985L (es)
NZ (1) NZ233546A (es)
PT (1) PT93946B (es)
YU (1) YU86390A (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
US5296472A (en) * 1991-12-05 1994-03-22 Vyrex Corporation Methods for delipidation of skin and cerumen removal
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
JP2001521002A (ja) * 1997-10-24 2001-11-06 コーネル リサーチ ファンデーション インク． 脳の代謝機能不全のための栄養補充剤
FI982733A (fi) 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7694694B2 (en) * 2004-05-10 2010-04-13 The Aerospace Corporation Phase-change valve apparatuses
EP2486942B1 (en) 2004-11-24 2018-10-10 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
EP2697662B1 (en) 2011-04-13 2018-06-06 Codexis, Inc. Biocatalytic process for preparing eslicarbazepine and analogs thereof
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US11938139B2 (en) 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US10898493B2 (en) 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (es) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
DE3575135D1 (de) * 1984-09-14 1990-02-08 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
EP0222191B1 (de) * 1985-11-11 1991-01-30 ASTA Pharma AG 4-Benzyl-1-(2H)-phthalazinon-Derivate
JPH0667844B2 (ja) * 1987-03-06 1994-08-31 エーザイ株式会社 虚血性心疾患の治療・予防剤
EP0289939A1 (de) * 1987-05-08 1988-11-09 ASTA Pharma AG Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest
US5232919A (en) * 1987-11-13 1993-08-03 Asta Pharma Aktiengesellschaft Azelastine embonate and compositions which contain it
ES2053679T3 (es) * 1987-11-13 1994-08-01 Asta Medica Ag Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo.
AU609210B2 (en) * 1987-11-13 1991-04-26 Viatris Gmbh & Co. Kg Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
JP2794021B2 (ja) * 1988-11-02 1998-09-03 エーザイ株式会社 アゼラスチン或いはその塩類含有経皮適用製剤

Also Published As

Publication number Publication date
US6017909A (en) 2000-01-25
DE4013696A1 (de) 1990-11-08
PT93946B (pt) 1996-11-29
NO901985D0 (no) 1990-05-04
JPH02295987A (ja) 1990-12-06
HUT53901A (en) 1990-12-28
NZ233546A (en) 1991-09-25
CA2016089A1 (en) 1990-11-05
NO901985L (no) 1990-11-06
PT93946A (pt) 1991-01-08
DD294254A5 (de) 1991-09-26
EP0396069B1 (de) 1994-06-22
AU622022B2 (en) 1992-03-26
IE901639L (en) 1990-11-05
DK0396069T3 (da) 1994-07-25
ATE107643T1 (de) 1994-07-15
CA2016089C (en) 1998-12-01
US5859003A (en) 1999-01-12
HU902678D0 (en) 1990-09-28
DE59006184D1 (de) 1994-07-28
EP0396069A1 (de) 1990-11-07
US5998403A (en) 1999-12-07
YU86390A (en) 1992-05-28
HU206110B (en) 1992-08-28
IE63662B1 (en) 1995-05-31
AU5473690A (en) 1990-11-08
ES2055216T3 (es) 1994-08-16
US5086050A (en) 1992-02-04

Similar Documents

Publication Publication Date Title
FI902244A0 (fi) Salter av azelastin, vilka har foerbaettrad loeslighet.
MX2007004763A (es) Acidos carboxilicos (bifenilo) y derivados de los mismos.
GT198400014A (es) Mejoras en o relativas a fenetanolaminas.
DK1572699T3 (da) Krystallinske cefdinirsalte
NO20014240D0 (no) C16-umettede FP-selektive prostaglandinanaloger
TW200504052A (en) Method for preparing acid addition salts of polyacidic basic compounds
NO20010552L (no) FremgangsmÕte for fremstilling av zofenopril kalsiumsalt
HU9300423D0 (en) Method for producing amino-methane-phosphonic acid and amino-methane-phosphinic one
ES2152097T3 (es) Empleo de esteres de acidos hidroxicarboxilicos como espesantes.
ATE270296T1 (de) Verfahren zur herstellung von hochkristallinem natrium cefoperazon
NZ514573A (en) Beta-hydroxyalkylamides, process for their production and their use
SE9903345D0 (sv) Novel process
DE69305773T2 (de) Herstellung von Diacetyl
DE602004012162D1 (de) Verfahren zur herstellung von dtpa-bis-anhydrid
DE50110250D1 (de) Verfahren zur herstellung von 3-aminoalkansäureestern
UA26982A1 (uk) Похідhі малоhової кислоти, які проявляють властивості іhгібітору росту рослиh
UA89215C2 (uk) Спосіб підвищення продуктивності сільськогосподарських культур
RO96974B1 (ro) Procedeu pentru stabilizarea produsului dinosebacetat
UA94574C2 (ru) (бифенил) карбоновые кислоты и их производные
ATE273289T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: ASTA MEDICA AKTIENGESELLSCHAFT